In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.
about
Early detection of diabetic kidney disease: Present limitations and future perspectivesNon-Proteinuric Diabetic NephropathyDiabetic Nephropathy and CKD-Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and PredictionHypoglycemia in Patients with Diabetes and Renal DiseaseChronic kidney disease screening methods and its implication for Malaysia: an in depth reviewPerspectives on systems biology applications in diabetic kidney diseaseInsights into the genetic architecture of diabetic nephropathyImprovements in the Management of Diabetic NephropathyA story of microalbuminuria and diabetic nephropathyDisease progression subtype discovery from longitudinal EMR data with a majority of missing values and unknown initial time pointsDiabetic Nephropathy: New Risk Factors and Improvements in DiagnosisStudy of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-upMulticentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Is the presence of microalbuminuria a relevant marker of kidney disease?Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetesDiabetic nephropathy - complications and treatment.GWAS of diabetic nephropathy: is the GENIE out of the bottle?Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetesProtein kinase C-β gene variants and type 2 diabetes-associated kidney failure: What can we learn from gene association studies in diabetic nephropathy?Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy.Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy.Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetesProgressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Serum cystatin C reflects the progress of albuminuria.Early renal function decline in type 2 diabetes.Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetesDiagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesElectrochemical Skin Conductance in Diabetic Kidney DiseaseUrinary Retinol-Binding Protein: Relationship to Renal Function and Cardiovascular Risk Factors in Chronic Kidney Disease.The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function declineRenin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.
P2860
Q26741494-A76FA340-4F12-4F98-A0F0-C265E9C212AFQ26786923-0D1259AA-C296-4B07-ADB8-581B6985B5E5Q26799432-52A2840E-6298-459C-BEA9-3DCE036151E8Q26799515-1BF84B4D-1A1E-4F1B-98FD-5A3FA01F7685Q26822369-ECBC8977-3F00-47E2-AA67-3FE63C14E399Q26823206-538BB73D-2496-43AF-AC5E-8C26605F8CE4Q26823352-367A68B4-E399-4E3D-B815-35B1927011AAQ28080717-475EBF42-00A0-469F-A234-B7C4189452E7Q30486667-34C7CE24-13BB-4E94-9E7C-22540393463AQ30946911-9766858D-4E57-4399-B1E0-B7A1DBA80469Q33583018-B4D8739C-6297-4918-A215-6EEB0E7BC62AQ33697462-FAD6BAC6-73AF-4175-BBC5-1933E697EC54Q33772238-6B2BFB5C-2632-4DF1-97C6-0E38987529BDQ33873169-0D5D7A21-5B87-43AA-9C79-5E74F3221EB9Q33985444-E5B8D5E8-FA88-4E10-8954-0EC4A8196D7CQ34138280-5DC92088-7326-49B0-AB05-1C546D23EB6BQ34256592-6DC33CF8-7D12-4226-B933-0007A9C40FAEQ34387952-43210368-3DC2-4AEF-A717-ADCC7609CD45Q34426648-D759FF61-8409-408E-A0A3-41C35BA4B00CQ34557348-91DF8966-60E5-4CD6-BCC4-84CF44200C18Q34568748-8000F2B9-1E6E-4FA4-A109-8ACAFC57A036Q34682583-EB4C8CD9-9451-4780-8413-1123F54E78FCQ34776598-ACC9B11D-F32C-4937-AE79-668BE8CA1314Q35009712-81DBD37C-16DA-4B17-BC1B-DAC5A50D7EF5Q35050798-45EBC2EA-C443-49BA-8397-24CB612AC909Q35248154-27824174-1154-4F3A-90C5-DA7CB864D4CDQ35627229-496D9B2C-955C-4B63-9419-E4D5C890CDA5Q35630730-FCA49FE6-FA20-4E2A-A9FB-09F4B2A171A0Q35661440-8C0EFCC6-0BD6-4F43-8FF0-BCFC97D6F7A6Q35692447-14091AA7-6530-42A6-92F2-93EDABEFA4C5Q35712111-D8B2A067-03F2-4C8A-8BFB-5AFAE2E786A3Q35804154-B9890BC7-6068-4C29-921B-F976D0A85475Q35817069-CBB01B72-3FDB-4C87-A153-9683B967F1DAQ35903097-374990A7-2248-4808-856A-8222EB7BA024Q36030852-3B22A6FD-2FC3-4E36-B37F-111D5CEBC0E5Q36140136-0C4BCEC7-9E84-42DE-B170-FD340E6B49F1Q36183114-F2C6D0BC-99D5-4E7E-8B42-81D3393455F7Q36311567-09E91C16-CFAF-427B-ABF0-6D4DB5EB162EQ36328889-7071C573-CFF1-4127-AB6D-B337FA7E5AE9Q36329456-9715D9F7-03F6-452D-BDF7-7E4030075E27
P2860
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In patients with type 1 diabet ...... re progression to proteinuria.
@en
In patients with type 1 diabet ...... re progression to proteinuria.
@nl
type
label
In patients with type 1 diabet ...... re progression to proteinuria.
@en
In patients with type 1 diabet ...... re progression to proteinuria.
@nl
prefLabel
In patients with type 1 diabet ...... re progression to proteinuria.
@en
In patients with type 1 diabet ...... re progression to proteinuria.
@nl
P2093
P2860
P356
P1433
P1476
In patients with type 1 diabet ...... ire progression to proteinuria
@en
P2093
Andrzej S Krolewski
Bijan Roshan
Bruce A Perkins
James H Warram
P2860
P2888
P356
10.1038/KI.2009.399
P407
P577
2010-01-01T00:00:00Z